Skip to content

DS MEDIC

Active Private limited companyfounded 2014active for 11 yearsRue Fosse-Roulette 23, 6690 VielsalmKBO/BCE: BE 0567.955.685

Timeline

23 events since 2014

The 2026 accounts are due by 30-04-2027.

2026
Annual accounts 2025 filed PDFmicro format · 58 days before the deadline
2025
Liquidity more than doubled current ratio 49.82 The current ratio rises from 21.33 to 49.82. Short-term debt falls from €34,807 to €17,285.
Annual accounts 2024 filed PDFmicro format · 4 days before the deadline
2024
Highest result from 2016 to 2025 net €191,600 ▲2.7% The operating result of €277,432 and the net result of €191,600 are both a record.
Annual accounts 2023 filed PDFmicro format · on the deadline day
2023
Liquidity more than triples current ratio 28.85 The current ratio rises from 7.80 to 28.85. Short-term debt falls from €65,126 to €20,346.
Equity above €500,000 equity €579,597 ▲40.2% With a profit in every financial year since 2016, equity grows to €579,597.
Annual accounts 2022 filed PDFmicro format · 3 days before the deadline
(director) and (director) reappointedGeneral meeting of 15-02-20235 points ▸
  • General meeting, 15-02-2023
  • 186 shares
  • Director reappointment, (director (not named in the articles))
  • Director reappointment, (director (not named in the articles))
  • Registered office clause, Rue Fosse-Roulette 23, 6690 Vielsalm
  • The deed holds 5 more points.

Open the deed in the Belgian Official Gazette

2022
Resignations & appointmentsGeneral meeting of 31-07-20221 point ▸
  • General meeting, 31-07-2022
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

Annual accounts 2021 filed PDFmicro format · 2 days before the deadline
2021
Equity above €200,000 equity €309,618 ▲59.6% With a profit in every financial year since 2016, equity grows to €309,618.
Annual accounts 2020 filed PDFmicro format · 28 days before the deadline
2020
Equity above €150,000 equity €193,975 ▲73.8% With a profit in every financial year since 2016, equity grows to €193,975.
Annual accounts 2019 filed PDFmicro format · 2 days before the deadline
2019
Equity above €100,000 equity €111,581 ▲76.5% With a profit in every financial year since 2016, equity grows to €111,581.
Annual accounts 2018 filed PDFmicro format · 33 days before the deadline
2018
Weakest financial year net €1,521 ▼88.9% The net result drops to €1,521, the lowest from 2016 to 2025. It recovers the following year.
Annual accounts 2017 filed PDFmicro format · 4 days before the deadline
2017
Registered office moved from Liermeux to VielsalmThe registered office moved from Petit-Sart 38-4990 Liermeux to Rue Fosse-Roulette 23-6690 Vielsalm · General meeting of 19-06-20172 points ▸
  • General meeting, 19-06-2017
  • Registered-office move, Rue Fosse-Roulette 23-6690 Vielsalm

Open the deed in the Belgian Official Gazette

Annual accounts 2016 filed PDFfull format · 2 days before the deadline
2014
IncorporationFounding capital of €18,600, 186 shares · Founded by and · (manager) and (manager) appointed · published on 24-11-20147 points ▸
  • Board rule, 2
  • Director appointment, (manager)
  • Director appointment, (manager)
  • Founder,
  • Founder,
  • Founding capital, €18,600, 186 shares
  • Capital, €18,600, 186 shares
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

First establishment At the time the registered office was still in Liermeux, Petit-Sart 38.

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 20 November 2014, DS MEDIC was incorporated by three private individuals, with a starting capital of €18,600.12 In 2017 the registered office moved to Vielsalm.3 Of the 2 current board members, 2 have served since 2023.4 Total assets went from €364,027 in 2019 to €909,799 in 2025.5

  1. 1KBO register
  2. 2Belgian Official Gazette, 24-11-2014
  3. 3Belgian Official Gazette, 07-08-2017
  4. 4National Bank, annual accounts 2025
  5. 5National Bank, annual accounts 2019 and 2025

Next steps